FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Animal Drugs

Midwest Vet Supply Forfeits $10 Million for Misbranding

Midwest Veterinary Supply agrees to pay more than $10 million in forfeiture and fines as part of a plea agreement for misbranding prescription veterin...

latest-news-card-1
Medical Devices

AI/ML Software Marketing Submission Guidance

FDA publishes a draft guidance recommending the information to be included in a predetermined change control plan in a marketing submission for a mach...

latest-news-card-1
Medical Devices

VALID Act Reintroduced

Reps. Buschon and DeGette reintroduce the bipartisan VALID Act to reform the regulation of diagnostic tests by FDA and the Centers for Medicare and Me...

latest-news-card-1
Human Drugs

Research on Some Child Subjects Guidance

FDA publishes a draft guidance to assist in understanding the processes used for the review of some research involving children as subjects that is no...

latest-news-card-1
Biologics

Align Global Gene, Cell Therapy Regulation: Marks

CBER director Peter Marks says hed like to see aligned global regulations to boost commercialization for gene and cell therapies.

latest-news-card-1
Medical Devices

FDA Approves Abbotts Epic Max Heart Valve

FDA approves an Abbott PMA supplement for Epic Max, a stented tissue valve to treat people with aortic regurgitation or stenosis.

latest-news-card-1
Human Drugs

FDA Converts 1 Keytruda Indication to Full Approval

FDA converts Mercks Keytruda immunotherapy from accelerated to full approval for treating certain solid tumors

latest-news-card-1
FDA General

Califf Says GOP Budget Cuts Would Devastate FDA

FDA commissioner Robert Califf tells House appropriators that reported plans on budget cuts of up to 22% being floated by Republican lawmakers would h...

latest-news-card-1
Human Drugs

Clinical Hold Lifted on Vigil Neuros VGL101

FDA lifts its partial clinical hold against Vigil Neuroscience and doses greater than 20 mg/kg for VGL101 in clinical trials in certain patients with ...

latest-news-card-1
Federal Register

Panel to Vote on Non-RX Birth Control Pill

Federal Register notice: FDA announces a 5/9 Advisory Committee meeting to discuss a non-RX birth control pill.